Vasomotor Symptoms
51
6
7
35
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
14 trials with published results (27%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.9%
3 terminated out of 51 trials
92.1%
+5.6% vs benchmark
31%
16 trials in Phase 3/4
40%
14 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (51)
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong
Vasomotor Symptoms in Post-Hysterectomy Women With Ovarian Conservation
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms
Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).
Stellate Ganglion Blockade in Post-Menopausal Women
A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause
A Survey About Hot Flashes in Women Going Through the Menopause
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women